Wydanie 1/2015
str. 20

Terapia zwyrodnienia plamki związanego z wiekiem

Current Treatment of Age-related Macular Degeneration

Aleksandra Kuźnik-Borkowska, Monika Turczyńska, Dariusz Kęcik

Klinika Chorób Oczu Warszawskiego Uniwersytetu Medycznego
Kierownik: prof. dr hab. n. med. Dariusz Kęcik


Summary: Treatment modalities in age-related macular degeneration. Review of disponible therapies from laser photocoagulation, photodynamic therapy with Visudyne to brachytherapy, submacular surgery and intraocular inhibition of VEGF, as one of the most efficient therapies in medicine. Unresolved debates about the use of “off label” substances. Innovations in diagnostic technologies, such as optical coherence tomography and gold standard of fluorescein angiography. Improvement in the prognosis of patients with neovascular age-related macular degeneration, allowing in the majority of patients maintenance of visual function but burden of disease and burden of care, with a dissociation of clinical studies outcomes and real-world results. Management of age-related macular degeneration – indications, various recommandations in clinical practice and choice of available regimens of treatment and adequate monitoring needs.

Słowa kluczowe: Age-related macular degeneration, iniekcje doszklistkowe, optical coherence tomography, fluorescein angiography, anty-VEGF, rekombinowany tkankowy aktywator plazminogenu – rTPA.

Keywords: zage-related macular degeneration, intravitreal injections, optical coherence tomography, fluorescein angiography, anti-VEGF, tissue plasminogen activator – rTPA.


powrót

REDAKCJA NIE UDZIELA PORAD MEDYCZNYCH I NIE POŚREDNICZY W KONSULTACJACH PACJENTÓW Z LEKARZAMI